IFLR1000

Zur Rose Group SFr 175 million 0.275% bond issue

31/3/2020
Investment grade bond/note issue
Select tab

SFr 175 million

$ 180 million

Completed

31/3/2020

Overview:

  • Zur Rose Group, the Swiss pharmaceutical e-commerce company, has placed SFr 175 million 0.275% bonds due 2025 on the SIX Swiss Exchange, through its subsidiary Zur Rose Finance. 
  • The bonds are guaranteed and convertible into Zur Rose Group shares. 
  • Proceeds of the issuance will be used to facilitate growing medication demand on online pharmacies during the COVID-19 pandemic.

Natasha Forrest - Researcher

Jurisdiction:

Switzerland

Deal type:

Investment grade bond/note issue

Practice area:

Capital markets : Debt

Industry sector:

Pharmaceuticals and life sciences

Firms:
Baker McKenzie

Party: Zur Rose Group (Issuer)

Lawyer: Matthias Courvoisier

Bär & Karrer

Party: Merrill Lynch International (Joint global coordinator, Joint bookrunner)

Party: UBS (Joint bookrunner, Joint global coordinator)

Related deals